ubenimex has been researched along with Prostatic Neoplasms in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Denny, WA; Gynther, M; Huttunen, J; Huttunen, KM; Puris, E; Spicer, JA | 1 |
Bi, D; Cui, M; Han, L; Jia, Y; Liu, S; Liu, Z; Niu, Z; Wang, X; Zhang, Y | 1 |
Hioki, T; Hirano, K; Ishii, K; Sugimura, Y; Tatematsu, M; Usui, S; Yamamoto, H; Yoshida, S | 1 |
Hirokawa, I; Ichikawa, T; Ishihara, Y | 1 |
4 other study(ies) available for ubenimex and Prostatic Neoplasms
Article | Year |
---|---|
A Selective and Slowly Reversible Inhibitor of l-Type Amino Acid Transporter 1 (LAT1) Potentiates Antiproliferative Drug Efficacy in Cancer Cells.
Topics: Animals; Antineoplastic Agents; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Imidazoles; Large Neutral Amino Acid-Transporter 1; Male; MCF-7 Cells; Mice; Molecular Structure; Prostatic Neoplasms; Pyridines; Structure-Activity Relationship | 2016 |
Ubenimex inhibits cell proliferation, migration and invasion by inhibiting the expression of APN and inducing autophagic cell death in prostate cancer cells.
Topics: Animals; Antineoplastic Agents; Autophagy; CD13 Antigens; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Gene Expression Regulation, Neoplastic; Humans; Leucine; Male; Mice; Mice, Nude; Neoplasm Invasiveness; Prostatic Neoplasms; Xenograft Model Antitumor Assays | 2016 |
Aminopeptidase N regulated by zinc in human prostate participates in tumor cell invasion.
Topics: Amino Acid Sequence; CD13 Antigens; Copper; Dose-Response Relationship, Drug; Edetic Acid; Egtazic Acid; Enzyme Inhibitors; Epithelium; Humans; Immunohistochemistry; Leucine; Male; Neoplasm Invasiveness; Peptide Fragments; Phenanthrolines; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Substrate Specificity; Tumor Cells, Cultured; Zinc | 2001 |
[Clinical studies of bestatin on genitourinary cancer].
Topics: Adjuvants, Immunologic; Aged; Antibiotics, Antineoplastic; Female; Humans; Kidney Neoplasms; Leucine; Male; Middle Aged; Penile Neoplasms; Prostatic Neoplasms; Ureteral Neoplasms; Urinary Bladder Neoplasms; Urogenital Neoplasms | 1985 |